Dr. Fallon’s research focuses on the overlap between medicine, neurology, and psychiatry. Dr Fallon has conducted
numerous NIH-funded clinical trials, including serving as principal investigator on the NINDS retreatment study of
Persistent Post-treatment Lyme Encephalopathy. His team’s studies of post-treatment Lyme disease have demonstrated
deficits in brain blood flow and metabolism and delineated the neurocognitive and neuropsychiatric sequelae.
Dr. Delaney’s research on Borrelia miyamotoi adds a spotlight to this little known but common tick-borne infection.
Board-certified in child and adult psychiatry, Dr. Delaney’s particular expertise is in immune and infectious biomarkers
of neuropsychiatric disorders.
Dr. Aucott’ s research is focused on improved diagnostic testing and health related outcomes for all the stages of Lyme disease.
His particular expertise is on understanding the cause, optimal diagnosis and treatment of persistent symptoms in Lyme disease.
He is currently the Principal Investigator for the SLICE studies which have been pivotal in elucidating the immunologic profile
of early and late manifestations of Lyme disease and examining the impact of acute and chronic Lyme disease on health outcomes
and the human immune system.
Dr. DeBiasi’s extensive clinical and research expertise includes basic science and clinical/ translational research.
Current research includes a study evaluating the burden of pediatric Lyme disease and its long-term outcomes in children.
Dr. DeBiasi is principal investigator on multiple clinical trials addressing the impact and treatment of severe viral infections
affecting pregnant women, neonates, immunocompromised hosts, and normal children. Dr. DeBiasi currently serves on a Tick-Borne
Disease Working Group subcommittee established in 2018 by the Department of Health and Human Services.
The Lyme Clinical Trials Network Team
Brian A. Fallon, MD, MPH is the director of the Lyme and Tick-Borne Diseases Research Center at Columbia University
and of the two new Cohen-funded initiatives – the new translational clinical Center for Health and Recovery and the
national CTN Coordinating Center.
Shannon Delaney, MD, is co-director of the Cohen Center for Health and Recovery from Tick-borne Diseases as well as
director of pediatric neuropsychiatric research for the Lyme and Tick-borne Diseases Research Center.
John Nathaniel Aucott, M.D., is an Associate Professor of medicine at the Johns Hopkins University School of Medicine
and a CTN Node Principal Investigator and CTN Executive Committee Member
Roberta Lynn DeBiasi, M.D., M.S., is the Chief of the Division of Pediatric Diseases and Co-Director of the Congenital Zika
Program at Children's National Hospital a CTN Node Principal Investigator and CTN Executive Committee Member
Martina Pavlicova, PhD, is an Associate Professor of
Biostatistics at the Columbia University Medical Center and the CTN Senior Statistician and Executive Committee Member
Richard Buchsbaum is the Director of the Data Management Unit in the Department of Biostatistics
at the Mailman School of Public Health, Columbia University, and the CTN Data Center Director and Executive Committee Member
Mara Kuvaldina, PhD, is Associate Director and Research Coordinator of the CTN. Dr. Kuvaldina also serves as Research Scientist
for the Lyme and Tick-Borne Diseases Research Center at Columbia University.